ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Tennessee » Internal Medicine

Top Internal Medicine Prescribers in Tennessee

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PANKAJ SRIVASTAVA MD

Internal Medicine

60,946

$3.19M

1354
689 are 65+

19%
patients receiving schedule two controlled substances

Avg: 5%

41%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $55

JONATHAN ALLRED MD

Internal Medicine

47,760

$2.56M

1072
725 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

24%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $55

MICHAEL COX M.D.

Internal Medicine

47,264

$2.46M

1292
835 are 65+

17%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $55

ANGELA WATSON DO

Internal Medicine

45,819

$2.55M

843
656 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

30%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $55

DONALD QUINN MD

Internal Medicine

45,721

$1.97M

877
748 are 65+

18%
patients receiving schedule two controlled substances

Avg: 5%

35%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $55

LOU ANNE ZIBAS MD

Internal Medicine

36,528

$1.73M

611
539 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $55

JOHN WILLIAMS M.D.

Internal Medicine

34,705

$1.51M

935
767 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $55

NABIL CYLEMAN MD

Internal Medicine

33,260

$1.43M

849
344 are 65+

35%
patients receiving schedule two controlled substances

Avg: 5%

55%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $55

DOUGLAS DYCUS M.D.

Internal Medicine

31,886

$1.34M

697
562 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $55

THOMAS EVANS M.D.

Internal Medicine

29,910

$1.38M

633
533 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

27%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $55

KENYA KOZAWA M.D.

Internal Medicine

29,794

$3M

1327
658 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$101
Average prescription price

Avg: $55

JONATHAN BREMER M.D.

Internal Medicine

29,217

$1.09M

653
565 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$37
Average prescription price

Avg: $55

TANVEER ASLAM M.D.

Internal Medicine

28,090

$1.83M

663
416 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $55

AJITKUMAR KEMKAR MD

Internal Medicine

27,454

$1.38M

677
295 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

44%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $55

FELIX NNAJI MD

Internal Medicine

27,432

$1.23M

710
397 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

39%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $55

VIVIAN CLARK M.D.

Internal Medicine

27,150

$1.44M

671
570 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

26%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $55

SAMIR RAHBE MD

Internal Medicine

26,135

$1.39M

807
620 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $55

JOE APPLETON MD

Internal Medicine

25,892

$1.07M

642
488 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $55

RICHARD PHELPS M.D.

Internal Medicine

25,848

$1.49M

947
699 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

25%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $55

MOHAMMAD RAHMAN M.D.

Internal Medicine

25,442

$1.27M

810
652 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $55

DAVID GUTHRIE MD

Internal Medicine

25,403

$1.05M

861
718 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $55

RICHARD SMITH M.D.

Internal Medicine

25,218

$1.49M

1313
544 are 65+

43%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $55

IMHONA EKO-ISENALUMHE M.D

Internal Medicine

25,190

$1.26M

545
192 are 65+

43%
patients receiving schedule two controlled substances

Avg: 5%

47%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $55

JAWAID KAMAL MD

Internal Medicine

24,822

$1.13M

861
604 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

39%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $55

TODD TEAGUE MD

Internal Medicine

24,707

$1.16M

824
711 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $55

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank